Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo.
Dorđić M, Matić IZ, Filipović-Lješković I, Džodić R, Sašić M, Erić-Nikolić A, Vuletić A, Kolundžija B, Damjanović A, Grozdanić N, Nikolić S, Pralica J, Dobrosavljević D, Rašković S, Andrejević S, Juranić Z. Dorđić M, et al. BMC Complement Altern Med. 2012 Jul 26;12:109. doi: 10.1186/1472-6882-12-109. BMC Complement Altern Med. 2012. PMID: 22834951 Free PMC article.
Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.
Damjanović A, Matić IZ, Ðorđić M, Ðurović MN, Nikolić S, Roki K, Milovanović Z, Antić-Stanković J, Džodić R, Damjanović S, Kanjer K, Abu Rabi Z, Juranić Z. Damjanović A, et al. Pathol Oncol Res. 2015 Jul;21(3):605-12. doi: 10.1007/s12253-014-9864-9. Epub 2014 Oct 29. Pathol Oncol Res. 2015. PMID: 25351941 Free article.
Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels.
Mirjačić Martinović KM, Babović NL, Džodić RR, Jurišić VB, Ninković AZ, Konjević GM. Mirjačić Martinović KM, et al. Among authors: dzodic rr. Melanoma Res. 2016 Dec;26(6):551-564. doi: 10.1097/CMR.0000000000000289. Melanoma Res. 2016. PMID: 27623136
70 results